Correlation Between Eliem Therapeutics and Virpax Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and Virpax Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and Virpax Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eliem Therapeutics and Virpax Pharmaceuticals, you can compare the effects of market volatilities on Eliem Therapeutics and Virpax Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of Virpax Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and Virpax Pharmaceuticals.
Diversification Opportunities for Eliem Therapeutics and Virpax Pharmaceuticals
0.53 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Eliem and Virpax is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and Virpax Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Virpax Pharmaceuticals and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with Virpax Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Virpax Pharmaceuticals has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and Virpax Pharmaceuticals go up and down completely randomly.
Pair Corralation between Eliem Therapeutics and Virpax Pharmaceuticals
Given the investment horizon of 90 days Eliem Therapeutics is expected to generate 0.74 times more return on investment than Virpax Pharmaceuticals. However, Eliem Therapeutics is 1.36 times less risky than Virpax Pharmaceuticals. It trades about -0.21 of its potential returns per unit of risk. Virpax Pharmaceuticals is currently generating about -0.29 per unit of risk. If you would invest 383.00 in Eliem Therapeutics on September 1, 2024 and sell it today you would lose (79.00) from holding Eliem Therapeutics or give up 20.63% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 95.24% |
| Values | Daily Returns |
Eliem Therapeutics vs. Virpax Pharmaceuticals
Performance |
| Timeline |
| Eliem Therapeutics |
| Virpax Pharmaceuticals |
Eliem Therapeutics and Virpax Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eliem Therapeutics and Virpax Pharmaceuticals
The main advantage of trading using opposite Eliem Therapeutics and Virpax Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, Virpax Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virpax Pharmaceuticals will offset losses from the drop in Virpax Pharmaceuticals' long position.| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
| Virpax Pharmaceuticals vs. Revelation Biosciences | Virpax Pharmaceuticals vs. Palisade Bio | Virpax Pharmaceuticals vs. Virax Biolabs Group | Virpax Pharmaceuticals vs. Quoin Pharmaceuticals Ltd |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |